Orpyx® (Hardware, Health Care) — Funding, Investors & Signals 2026

Orpyx®

Diabetes Healthspan Extension

Founded 2010 Canada

Calgary, Canada 69 employees Series A Total: $16.30M Hardware, Health Care +2

Orpyx® is a leading digital therapeutics company committed to extending healthspan for people living with diabetes through personalized remote care. Their flagship product, the Orpyx® Sensory Insoles, is transforming diabetes care by helping prevent diabetic foot ulcers, a major complication that can lead to amputation. This Canadian-based company, founded in 2010, boasts a dedicated remote patient monitoring team comprised of credentialed providers and nurses. They utilize advanced data science methodologies to provide personalized support and triaged clinical escalation. With a whole-person approach, Orpyx empowers people to take control of their health, prevent debilitating complications, and extend their healthspan. In their latest funding round, Orpyx secured a $7.60M Series A investment on 08 July 2020. Key investors in this round include Anges Québec, Aphelion Capital, InterGen Capital, Thin Air Labs, Viewpoint, ICM Asset Management, Paddock Capital, Relentless Pursuit Partners, and Picante Capital. This impressive support from a diverse group of investors signifies the recognition of Orpyx's potential to make a significant impact in the health care industry. In summary, Orpyx is positioned at the forefront of utilizing digital therapeutics to enhance the lives of individuals with diabetes. Their innovative approach and recent substantial investment demonstrate their potential for long-term success in this crucial health care sector.

Funding Stage	Amount	Investors	Lead Investors	Date
Series A	••••••	9	•••• ••••	08 Jul 2020
Convertible Note	••••••	-		26 Oct 2018
Venture Round	••••••	-		27 Feb 2018
Non Equity Assistance	••••••	1		18 Oct 2017
Venture Round	••••••	-		01 Jan 2017

Funding Stage

Amount

Investors

Lead Investors

Date

Series A

••••••

•••• ••••

08 Jul 2020

Convertible Note

••••••

26 Oct 2018

Venture Round

••••••

27 Feb 2018

Non Equity Assistance

••••••

18 Oct 2017

Venture Round

••••••

01 Jan 2017

FAQ About Orpyx®

Diabetes Healthspan Extension

Orpyx® was founded in 2010.

Orpyx® is headquartered in Calgary, Canada.

Orpyx® operates in the following industries: Hardware, Health Care, Health and Wellness, Medical Devices.

Orpyx® has approximately 69 employees.

Orpyx® has completed 7 funding rounds, raising a total of $16.30M. The latest funding stage is Series A.

Top alternatives and competitors to Orpyx® include Diabeter, Ascensia Diabetes Care, RPM Logix, Stēto, OneTwo Analytics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Orpyx® and Diabeter are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Orpyx®

General Information

Track Orpyx®

Discover More

About Orpyx®

Funding Rounds & Investors (7)

Orpyx® Alternatives & Competitors

FAQ About Orpyx®

Don't just browse. Track.